These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9757787)

  • 21. Soft tissue tumours: the impact of cytogenetics and molecular genetics.
    Fletcher CD
    Verh Dtsch Ges Pathol; 1997; 81():318-26. PubMed ID: 9474886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of immunocytochemistry in the diagnosis of soft tissue sarcomas: a review and update.
    Ordóñez NG
    Adv Anat Pathol; 1998 Mar; 5(2):67-85. PubMed ID: 9868514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soft tissue small round cell tumors: morphological parameters.
    d'Amore ES; Ninfo V
    Semin Diagn Pathol; 1996 Aug; 13(3):184-203. PubMed ID: 8875709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors.
    Fletcher JA; Kozakewich HP; Hoffer FA; Lage JM; Weidner N; Tepper R; Pinkus GS; Morton CC; Corson JM
    N Engl J Med; 1991 Feb; 324(7):436-42. PubMed ID: 1988828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas.
    Suehara Y; Kondo T; Fujii K; Hasegawa T; Kawai A; Seki K; Beppu Y; Nishimura T; Kurosawa H; Hirohashi S
    Proteomics; 2006 Aug; 6(15):4402-9. PubMed ID: 16807943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastases to soft tissue: a review of 118 cases over a 30-year period.
    Plaza JA; Perez-Montiel D; Mayerson J; Morrison C; Suster S
    Cancer; 2008 Jan; 112(1):193-203. PubMed ID: 18040999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of galectin-3 expression by sarcomas, pseudosarcomatous and benign lesions of the soft tissues. Preliminary results of an immunohistochemical study.
    Bigotti G; Coli A; Del Vecchio M; Massi G
    J Exp Clin Cancer Res; 2003 Jun; 22(2):255-64. PubMed ID: 12866576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemistry of soft tissue tumours: a review.
    du Boulay CE
    J Pathol; 1985 Jun; 146(2):77-94. PubMed ID: 2989470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemangiopericytoma: histopathological pattern or clinicopathologic entity?
    Nappi O; Ritter JH; Pettinato G; Wick MR
    Semin Diagn Pathol; 1995 Aug; 12(3):221-32. PubMed ID: 8545589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of soft tissue sarcomas in 1118 cases.
    Fang ZW; Chen J; Teng S; Chen Y; Xue RF
    Chin Med J (Engl); 2009 Jan; 122(1):51-3. PubMed ID: 19187617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
    Hasegawa T
    Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
    Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
    Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [WHO classification of testicular tumors].
    Mikuz G
    Verh Dtsch Ges Pathol; 2002; 86():67-75. PubMed ID: 12647353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new molecular variant of desmoplastic small round cell tumor: significance of WT1 immunostaining in this entity.
    Murphy AJ; Bishop K; Pereira C; Chilton-MacNeill S; Ho M; Zielenska M; Thorner PS
    Hum Pathol; 2008 Dec; 39(12):1763-70. PubMed ID: 18703217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cutaneous and subcutaneous soft tissue tumors].
    Meister P
    Verh Dtsch Ges Pathol; 1998; 82():112-20. PubMed ID: 10095423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical relevance of molecular genetics in soft tissue sarcomas.
    Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
    Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group.
    Mertens F; Strömberg U; Mandahl N; Dal Cin P; De Wever I; Fletcher CD; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van Den Berghe H; Vanni R; Willén H
    Cancer Res; 2002 Jul; 62(14):3980-4. PubMed ID: 12124330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Soft tissue sarcomas: current data in the field of pathology].
    Collin F; Gelly-Marty M; Bui Nguyen Binh M; Coindre JM
    Cancer Radiother; 2006; 10(1-2):7-14. PubMed ID: 16310396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant MAD2 expression in soft-tissue sarcoma.
    Hisaoka M; Matsuyama A; Hashimoto H
    Pathol Int; 2008 Jun; 58(6):329-33. PubMed ID: 18477210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant immunohistochemical expression in nonrhabdomyosarcoma soft tissue sarcomas of infancy: retrospective review of clinical material.
    Sebire NJ; Ramsay AD; Levitt G; Malone M; Risdon RA
    Pediatr Dev Pathol; 2002; 5(6):579-86. PubMed ID: 12370769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.